Home
HUMAW

HUMAW

Humacyte Inc. Warrant

as of 12-16-2025 12:05pm EST

$0.12

$0.03

-17.75%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Chart Type:

Time Range:

Founded:	2004	Country:	United States
Employees:	220	City:	DURHAM
Market Cap:	N/A	IPO Year:	N/A
Target Price:	N/A	AVG Volume (30 days):	14.2K
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-1.36	EPS Growth:	N/A
52 Week Low/High:	$1.18 - $1.34	Next Earning Date:	03-21-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered HUMAW Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold

Model Accuracy: 70.31%

70.31%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full HUMAW Forecast & Prediction with Hourly Data

Compare HUMAW vs Leading Stocks

See how HUMAW stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free HUMAW Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "HUMAW Humacyte Inc. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.